by Co-Diagnostics | Jun 11, 2018 | News Release
SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX), (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that they will... by Co-Diagnostics | Jun 5, 2018 | News Release
Proof of concept study successful in demonstrating potential SNP multiplexing applications SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique,... by Co-Diagnostics | Jun 1, 2018 | News Release
CoPrimers™ used in proof of concept evaluation SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX), a diagnostics company with a unique, proprietary platform for the development of molecular diagnostics, announced today that the... 